Bosentan-Mepha 62.5 mg
Bosentan-Mepha 62.5 mg is a medicine authorised by Swissmedic under authorisation number 65991. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 21 March 2017 and the authorisation is valid without a time limit. ATC code C02KX01 places the medicine in the group Antihypertensives.
| Authorisation number | 65991 |
|---|---|
| Name | Bosentan-Mepha 62.5 mg |
| Full name | Bosentan-Mepha 62.5 mg, Filmtabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C02KX01 |
| First authorisation | 21 March 2017 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Bosentan-Mepha 62.5 mg, Filmtabletten | B | 21 March 2017 |
| 2 | Bosentan-Mepha 125 mg, Filmtabletten | B | 21 March 2017 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 14 | Tablette(n) | C02KX01 | 02.07.1. | B |
| 2 | 56 | Tablette(n) | C02KX01 | 02.07.1. | B |
| 3 | 14 | Tablette(n) | C02KX01 | 02.07.1. | B |
| 4 | 56 | Tablette(n) | C02KX01 | 02.07.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Bosentan-Mepha 62.5 mg authorised in Switzerland?
Yes. Bosentan-Mepha 62.5 mg is authorised by Swissmedic under authorisation number 65991, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Bosentan-Mepha 62.5 mg have?
Bosentan-Mepha 62.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Bosentan-Mepha 62.5 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.